Bernd van der Loo
Overview
Explore the profile of Bernd van der Loo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
H Fischer A, van der Loo B, M Shar G, Zbinden R, Duru F, Brunckhorst C, et al.
Clin Cardiol
. 2008 Jul;
31(10):469-71.
PMID: 18666174
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an important cause of sudden death in young adults. On the basis of histopathological findings its pathogenesis may involve both a genetic origin...
12.
Schildknecht S, van der Loo B, Weber K, Tiefenthaler K, Daiber A, Bachschmid M
Free Radic Biol Med
. 2008 Jun;
45(4):512-20.
PMID: 18514074
Aggregation of activated platelets is considerably mediated by the autocrine action of thromboxane A2 (TxA2) which is formed in a prostaglandin endoperoxide H2 synthase-1 (PGHS-1 or COX-1)-dependent manner. The activity...
13.
Spring S, Simon R, van der Loo B, Kovacevic T, Brockes C, Rousson V, et al.
Thromb Haemost
. 2008 Jan;
99(1):182-9.
PMID: 18217152
Beneficial effects of aggressive lipid-lowering with high-dose atorvastatin (80 mg/day) have been demonstrated in patients with coronary and cerebrovascular disease. The impact of such a therapy in patients with peripheral...
14.
Tanner F, van der Loo B, Shaw S, Greutert H, Bachschmid M, Berrozpe M, et al.
Basic Res Cardiol
. 2007 Mar;
102(4):308-17.
PMID: 17356797
Objective: Nitric oxide (NO) inhibits thrombus formation, vascular contraction, and smooth muscle cell proliferation. We investigated whether NO release is enhanced after endothelial NO synthase (eNOS) gene transfer in atherosclerotic...
15.
16.
Koppensteiner R, Spring S, Amann-Vesti B, Meier T, Pfammatter T, Rousson V, et al.
J Vasc Surg
. 2006 Dec;
44(6):1247-53.
PMID: 17145426
Background: Restenosis after angioplasty is essentially due to intimal hyperplasia. Low-molecular-weight heparins (LMWHs) have experimentally been shown to have antiproliferative effects in addition to their antithrombotic properties. Their potential in...
17.
van der Loo B, Bachschmid M, Skepper J, Labugger R, Schildknecht S, Hahn R, et al.
Biochem Biophys Res Commun
. 2006 Apr;
344(3):972-80.
PMID: 16631605
Vascular aging is characterized by the presence of chronic oxidative stress. Although cytosolic Sod 1 has a key role in the detoxification of superoxide ((*)O(2)(-)), little is known about its...
18.
van der Loo B, Bachschmid M, Labugger R, Schildknecht S, Kilo J, Hahn R, et al.
Biogerontology
. 2006 Feb;
6(5):325-34.
PMID: 16463109
We investigated the effects of aging and ischemia-reperfusion (I/R) injury on the expression and activity of nitric oxide (*NO) synthases and superoxide dismutase (SOD) isoforms. To this end we perfused...
19.
Spring S, van der Loo B, Krieger E, Amann-Vesti B, Rousson V, Koppensteiner R
J Vasc Surg
. 2006 Jan;
43(1):56-63.
PMID: 16414387
Background: Wall shear stress, a local risk factor of atherosclerosis, is decreased in the common carotid artery of patients with vascular risk factors. We evaluated wall shear stress in the...
20.
Kaufmann P, Namdar M, Matthew F, Roffi M, Aschkenasy S, van der Loo B, et al.
J Nucl Med
. 2005 Aug;
46(8):1272-7.
PMID: 16085582
Unlabelled: Volumetric blood flow (Q) determination requires simultaneous assessment of mean blood flow velocity and vessel cross-sectional area. At present, no method provides both values. Intracoronary Doppler-based assessment of coronary...